Variant report

Variant	nsv1033325
Chromosome Location	chr6:34482287-34517857
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:1017)
CpG islands
(count:1894)
Chromatin interactive
region (count:106)
LncRNA
region (count:0)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:1017 , 50 per page) page: 1 2 3 4 5 6 7 ... 21

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ARID3A	chr6:34485472-34485719	K562	blood:	n/a	n/a
2	ARID3A	chr6:34495041-34495171	K562	blood:	n/a	n/a
3	ARID3A	chr6:34494959-34495288	HepG2	liver:	n/a	n/a
4	ARID3A	chr6:34494652-34494762	K562	blood:	n/a	n/a
5	ATF1	chr6:34498693-34498808	K562	blood:	n/a	n/a
6	ATF2	chr6:34494984-34495307	H1-hESC	embryonic stem cell:	n/a	n/a
7	ATF3	chr6:34485205-34485489	K562	blood:	n/a	n/a
8	BACH1	chr6:34494673-34494811	K562	blood:	n/a	n/a
9	BCLAF1	chr6:34494974-34495328	GM12878	blood:	n/a	n/a
10	BHLHE40	chr6:34512632-34512964	K562	blood:	n/a	n/a
11	BHLHE40	chr6:34481627-34482576	K562	blood:	n/a	n/a
12	BHLHE40	chr6:34495040-34495240	GM12878	blood:	n/a	n/a
13	BHLHE40	chr6:34494998-34495331	K562	blood:	n/a	n/a
14	BHLHE40	chr6:34498559-34498914	K562	blood:	n/a	n/a
15	BRCA1	chr6:34495142-34495167	HepG2	liver:	n/a	n/a
16	BRCA1	chr6:34495129-34495249	GM12878	blood:	n/a	n/a
17	CBX3	chr6:34494717-34495375	K562	blood:	n/a	n/a
18	CBX3	chr6:34504717-34505022	K562	blood:	n/a	n/a
19	CBX3	chr6:34485139-34485727	K562	blood:	n/a	n/a
20	CBX3	chr6:34512311-34513045	K562	blood:	n/a	n/a
21	CBX3	chr6:34498382-34499182	K562	blood:	n/a	n/a
22	CBX3	chr6:34499300-34499739	K562	blood:	n/a	n/a
23	CBX3	chr6:34486407-34486830	K562	blood:	n/a	n/a
24	CBX3	chr6:34504652-34505107	K562	blood:	n/a	n/a
25	CBX3	chr6:34486503-34486792	K562	blood:	n/a	n/a
26	CCNT2	chr6:34486987-34486989	K562	blood:	n/a	n/a
27	CCNT2	chr6:34512678-34512912	K562	blood:	n/a	n/a
28	CCNT2	chr6:34482363-34482613	K562	blood:	n/a	n/a
29	CCNT2	chr6:34494979-34495361	K562	blood:	n/a	chr6:34495055-34495064
30	CEBPB	chr6:34495072-34495287	H1-hESC	embryonic stem cell:	n/a	n/a
31	CEBPB	chr6:34512498-34512758	H1-hESC	embryonic stem cell:	n/a	chr6:34512601-34512612
32	CEBPB	chr6:34495028-34495242	Hela-S3	cervix:	n/a	n/a
33	CEBPB	chr6:34495110-34495201	HepG2	liver:	n/a	n/a
34	CEBPB	chr6:34497425-34497656	Hela-S3	cervix:	n/a	n/a
35	CEBPB	chr6:34494273-34494503	K562	blood:	n/a	chr6:34494374-34494385
36	CEBPB	chr6:34512444-34512756	A549	lung:	n/a	chr6:34512601-34512612
37	CEBPB	chr6:34512433-34512769	IMR90	lung:	n/a	chr6:34512601-34512612
38	CEBPB	chr6:34495064-34495309	K562	blood:	n/a	n/a
39	CEBPB	chr6:34512412-34512961	K562	blood:	n/a	chr6:34512601-34512612
40	CEBPB	chr6:34494289-34494459	HepG2	liver:	n/a	chr6:34494374-34494385
41	CEBPB	chr6:34504268-34505039	MCF-7	breast:	n/a	n/a
42	CEBPB	chr6:34512507-34512661	K562	blood:	n/a	chr6:34512601-34512612
43	CEBPB	chr6:34512447-34512874	K562	blood:	n/a	chr6:34512601-34512612
44	CEBPB	chr6:34512441-34512760	HepG2	liver:	n/a	chr6:34512601-34512612
45	CEBPD	chr6:34512514-34513045	K562	blood:	n/a	n/a
46	CHD2	chr6:34485455-34485478	K562	blood:	n/a	n/a
47	CHD2	chr6:34494932-34495311	K562	blood:	n/a	n/a
48	CHD2	chr6:34495004-34495272	H1-hESC	embryonic stem cell:	n/a	n/a
49	CHD2	chr6:34494942-34495251	Hela-S3	cervix:	n/a	n/a
50	CHD2	chr6:34499393-34499717	K562	blood:	n/a	n/a

(count:1894 , 50 per page) page: 1 2 3 4 5 6 7 ... 38

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr6:34499488-34499538	GM12892	blood:	n/a
2	chr6:34499504-34499554	SK-N-SH_RA	brain:	n/a
3	chr6:34486129-34486179	NB4	blood:	n/a
4	chr6:34499488-34499538	GM12892	blood:	n/a
5	chr6:34499504-34499554	SK-N-SH_RA	brain:	n/a
6	chr6:34486129-34486179	NB4	blood:	n/a
7	chr6:34504890-34504940	AG10803	skin:	n/a
8	chr6:34495393-34495443	NH-A	brain:	n/a
9	chr6:34505610-34505660	HCPEpiC	choroid plexus:	n/a
10	chr6:34482411-34482461	HepG2	liver:	n/a
11	chr6:34512253-34512303	AG04450	lung:	fetal
12	chr6:34512083-34512133	PANC-1	pancreas:	n/a
13	chr6:34504890-34504940	SKMC	muscle:	n/a
14	chr6:34508820-34508870	MCF10A-Er-Src	breast:	n/a
15	chr6:34492115-34492165	NH-A	brain:	n/a
16	chr6:34482479-34482529	HEEpiC	esophagus:	n/a
17	chr6:34495124-34495174	NB4	blood:	n/a
18	chr6:34482411-34482461	GM12892	blood:	n/a
19	chr6:34512215-34512265	HCT-116	colon:	n/a
20	chr6:34498714-34498764	HUVEC	blood vessel:	n/a
21	chr6:34495054-34495104	Caco-2	colon:	n/a
22	chr6:34493129-34493179	HIPEpiC	eye:	n/a
23	chr6:34499504-34499554	PANC-1	pancreas:	n/a
24	chr6:34482411-34482461	HCPEpiC	choroid plexus:	n/a
25	chr6:34495054-34495104	HCM	heart:	n/a
26	chr6:34508820-34508870	LNCaP	prostate:	n/a
27	chr6:34514887-34514937	GM12892	blood:	n/a
28	chr6:34489623-34489673	H1-hESC	embryonic stem cell:	embryo
29	chr6:34493129-34493179	HepG2	liver:	n/a
30	chr6:34482479-34482529	GM12878	blood:	n/a
31	chr6:34494976-34495026	CMK	blood:	n/a
32	chr6:34495292-34495342	HMEC	breast:	n/a
33	chr6:34508820-34508870	ovcar-3	ovarian:	n/a
34	chr6:34501193-34501243	SAEC	small airway:	n/a
35	chr6:34502119-34502169	GM06990	blood:	n/a
36	chr6:34514887-34514937	IMR90	lung:	fetal
37	chr6:34489623-34489673	AG04449	skin:	fetal
38	chr6:34495124-34495174	AG04450	lung:	fetal
39	chr6:34495124-34495174	T-47D	breast:	n/a
40	chr6:34495292-34495342	T-47D	breast:	n/a
41	chr6:34489552-34489602	PrEC	prostate:	n/a
42	chr6:34513187-34513237	NHBE	bronchial:	n/a
43	chr6:34495292-34495342	SAEC	small airway:	n/a
44	chr6:34499504-34499554	RPTEC	kidney:	n/a
45	chr6:34508820-34508870	HRPEpiC	eye:	n/a
46	chr6:34504890-34504940	PANC-1	pancreas:	n/a
47	chr6:34495393-34495443	HAEpiC	amniotic membrane:	n/a
48	chr6:34501193-34501243	HEEpiC	esophagus:	n/a
49	chr6:34511514-34511564	AG09319	gingival:	n/a
50	chr6:34499389-34499439	GM12878	blood:	n/a

(count:106 , 50 per page) page: 1 2 3

No.	Distal block	Cell Line	Cell type
1	chr6:34131307..34131807-chr6:34494733..34495454,2	K562	blood:
2	chr6:34509583..34511363-chr6:34518250..34520010,2	K562	blood:
3	chr6:34392344..34394131-chr6:34485515..34488152,2	MCF-7	breast:
4	chr6:34485669..34487625-chr6:34579770..34581445,2	K562	blood:
5	chr6:34216948..34217455-chr6:34494244..34495154,2	K562	blood:
6	chr6:34392363..34395361-chr6:34495918..34498856,2	K562	blood:
7	chr6:34497355..34498033-chr6:34557195..34557723,2	MCF-7	breast:
8	chr6:34473007..34475169-chr6:34486448..34488656,2	K562	blood:
9	chr6:34490944..34493717-chr6:34499736..34502529,2	K562	blood:
10	chr6:34514809..34519137-chr6:34522826..34525341,4	K562	blood:
11	chr6:34189603..34191937-chr6:34485538..34487216,2	MCF-7	breast:
12	chr6:34494049..34496847-chr6:34497897..34503319,6	K562	blood:
13	chr6:34507633..34511172-chr6:34512304..34515175,5	K562	blood:
14	chr6:34494831..34497738-chr6:34508657..34510396,2	MCF-7	breast:
15	chr6:34506980..34511719-chr6:34518115..34520438,4	K562	blood:
16	chr6:34478801..34483587-chr6:34487248..34491572,6	K562	blood:
17	chr6:34486477..34488245-chr6:34492452..34495163,2	MCF-7	breast:
18	chr6:34496932..34498060-chr6:34528153..34529212,4	MCF-7	breast:
19	chr6:34501585..34503222-chr6:34504276..34506644,2	K562	blood:
20	chr6:34494545..34497462-chr6:34498275..34503019,6	MCF-7	breast:
21	chr6:34505107..34506692-chr6:34515801..34518168,2	MCF-7	breast:
22	chr6:34486477..34488245-chr6:34492452..34495163,2	MCF-7	breast:
23	chr6:34497242..34499881-chr6:34564591..34566557,2	MCF-7	breast:
24	chr6:34392122..34394769-chr6:34484258..34486881,2	K562	blood:
25	chr6:34494831..34497738-chr6:34508657..34510396,2	MCF-7	breast:
26	chr6:34494038..34495878-chr6:34511727..34514586,2	K562	blood:
27	chr6:34514887..34517520-chr6:34540730..34542846,2	MCF-7	breast:
28	chr6:33686485..33689308-chr6:34514444..34516167,2	MCF-7	breast:
29	chr6:34495305..34497309-chr6:34500179..34501973,2	K562	blood:
30	chr6:34496140..34497736-chr6:34570571..34572929,2	MCF-7	breast:
31	chr6:34511760..34514306-chr6:34515453..34517552,2	K562	blood:
32	chr6:34496034..34498791-chr6:34510835..34512433,2	K562	blood:
33	chr6:34430319..34432535-chr6:34490428..34492193,2	MCF-7	breast:
34	chr6:34502654..34506400-chr6:34510960..34515406,9	MCF-7	breast:
35	chr6:34498308..34501187-chr6:34577541..34579069,2	MCF-7	breast:
36	chr6:34495679..34498360-chr6:34503054..34505628,3	MCF-7	breast:
37	chr6:34503239..34505474-chr6:34519140..34521426,2	MCF-7	breast:
38	chr6:34508607..34511346-chr6:34567639..34570139,2	K562	blood:
39	chr6:34391920..34394016-chr6:34508628..34510815,2	MCF-7	breast:
40	chr6:34502654..34506400-chr6:34510960..34515406,9	MCF-7	breast:
41	chr6:34495305..34497309-chr6:34500179..34501973,2	K562	blood:
42	chr6:34494680..34495634-chr6:34577124..34578035,2	MCF-7	breast:
43	chr6:34495679..34498360-chr6:34503054..34505628,3	MCF-7	breast:
44	chr6:34211149..34214132-chr6:34498415..34499975,2	K562	blood:
45	chr6:34433077..34435730-chr6:34480474..34482366,2	K562	blood:
46	chr6:34497164..34498159-chr6:34514567..34515376,2	MCF-7	breast:
47	chr6:34193853..34195785-chr6:34492922..34495154,2	K562	blood:
48	chr6:34494873..34497912-chr6:34521168..34524393,3	MCF-7	breast:
49	chr6:34514003..34515621-chr6:34528599..34531450,2	K562	blood:
50	chr6:34493240..34495795-chr6:34548549..34550240,2	K562	blood:

No data

Variant related genes	Relation type
PACSIN1	TF binding region
PACSIN1	CpG island
ENSG00000137309	chromatin interactions
ENSG00000124664	chromatin interactions
ENSG00000124614	chromatin interactions
ENSG00000196114	chromatin interactions
ENSG00000186577	chromatin interactions
ENSG00000270800	chromatin interactions
ENSG00000124507	chromatin interactions

Extended variants
information (count: 1536 )
Associated
traits (count: 106 )

Variant overlapped rSNPs/rCNVs (count:1536 , 50 per page) page: 1 2 3 4 5 6 7 ... 31

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs139920665	chr6:34482297-34482298	Active TSS Bivalent/Poised TSS Weak transcription Bivalent Enhancer Enhancers Flanking Bivalent TSS/Enh Flanking Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
2	rs546750621	chr6:34482307-34482308	Active TSS Bivalent/Poised TSS Weak transcription Bivalent Enhancer Enhancers Flanking Bivalent TSS/Enh Flanking Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
3	rs111992631	chr6:34482336-34482337	Active TSS Bivalent/Poised TSS Weak transcription Bivalent Enhancer Enhancers Flanking Bivalent TSS/Enh Flanking Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
4	rs146722612	chr6:34482339-34482340	Active TSS Bivalent/Poised TSS Weak transcription Bivalent Enhancer Enhancers Flanking Bivalent TSS/Enh Flanking Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
5	rs73407717	chr6:34482351-34482352	Active TSS Bivalent/Poised TSS Weak transcription Bivalent Enhancer Enhancers Flanking Bivalent TSS/Enh Flanking Active TSS	TF binding region Chromatin interactive region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
6	rs569664970	chr6:34482364-34482365	Active TSS Bivalent/Poised TSS Weak transcription Bivalent Enhancer Enhancers Flanking Bivalent TSS/Enh Flanking Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
7	rs372693561	chr6:34482384-34482385	Active TSS Bivalent/Poised TSS Weak transcription Bivalent Enhancer Enhancers Flanking Bivalent TSS/Enh Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
8	rs537472037	chr6:34482404-34482405	Active TSS Bivalent/Poised TSS Enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh Flanking Active TSS Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
9	rs558949212	chr6:34482407-34482408	Active TSS Bivalent/Poised TSS Enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh Flanking Active TSS Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
10	rs577449665	chr6:34482411-34482412	Active TSS Bivalent/Poised TSS Enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh Flanking Active TSS Weak transcription	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
11	rs535056582	chr6:34482412-34482413	Active TSS Bivalent/Poised TSS Enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh Flanking Active TSS Weak transcription	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
12	rs556772374	chr6:34482431-34482432	Active TSS Bivalent/Poised TSS Enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh Flanking Active TSS Weak transcription	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
13	rs575098539	chr6:34482443-34482444	Active TSS Bivalent/Poised TSS Enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh Flanking Active TSS Weak transcription	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
14	rs114621038	chr6:34482448-34482449	Active TSS Bivalent/Poised TSS Enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh Flanking Active TSS Weak transcription	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
15	rs200216691	chr6:34482455-34482456	Active TSS Bivalent/Poised TSS Enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh Flanking Active TSS Weak transcription	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
16	rs376101985	chr6:34482460-34482461	Active TSS Bivalent/Poised TSS Enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh Flanking Active TSS Weak transcription	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
17	rs563394698	chr6:34482461-34482462	Active TSS Bivalent/Poised TSS Enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh Flanking Active TSS Weak transcription	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
18	rs369507511	chr6:34482483-34482484	Active TSS Bivalent/Poised TSS Enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh Flanking Active TSS Weak transcription	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
19	rs575277837	chr6:34482493-34482494	Active TSS Bivalent/Poised TSS Enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh Flanking Active TSS Weak transcription	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
20	rs11758326	chr6:34482498-34482499	Active TSS Bivalent/Poised TSS Enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh Flanking Active TSS Weak transcription	TF binding region CpG island	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
21	rs563956205	chr6:34482509-34482510	Active TSS Bivalent/Poised TSS Enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh Flanking Active TSS Weak transcription	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
22	rs191532975	chr6:34482520-34482521	Active TSS Bivalent/Poised TSS Enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh Flanking Active TSS Weak transcription	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
23	rs143697172	chr6:34482524-34482525	Active TSS Bivalent/Poised TSS Enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh Flanking Active TSS Weak transcription	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
24	rs377370988	chr6:34482561-34482562	Active TSS Bivalent/Poised TSS Enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh Flanking Active TSS Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
25	rs561504214	chr6:34482600-34482601	Active TSS Bivalent/Poised TSS Enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh Flanking Active TSS Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
26	rs529056734	chr6:34482606-34482607	Bivalent/Poised TSS Enhancers Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Flanking Active TSS Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
27	rs151041809	chr6:34482626-34482627	Bivalent/Poised TSS Enhancers Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Flanking Active TSS Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
28	rs539393816	chr6:34482658-34482659	Bivalent/Poised TSS Enhancers Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Flanking Active TSS Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
29	rs569828298	chr6:34482680-34482681	Bivalent/Poised TSS Enhancers Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
30	rs537180732	chr6:34482698-34482699	Bivalent/Poised TSS Enhancers Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
31	rs552520343	chr6:34482738-34482739	Bivalent/Poised TSS Enhancers Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
32	rs570800532	chr6:34482739-34482740	Bivalent/Poised TSS Enhancers Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
33	rs372021491	chr6:34482752-34482753	Bivalent/Poised TSS Enhancers Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
34	rs558453802	chr6:34482766-34482767	Bivalent/Poised TSS Enhancers Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
35	rs370992890	chr6:34482773-34482774	Bivalent/Poised TSS Enhancers Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
36	rs535287595	chr6:34482819-34482820	Bivalent/Poised TSS Enhancers Bivalent Enhancer Flanking Active TSS Active TSS Flanking Bivalent TSS/Enh Weak transcription	n/a	n/a	Overlapped CNVs	n/a
37	rs184180544	chr6:34482838-34482839	Bivalent/Poised TSS Enhancers Bivalent Enhancer Flanking Active TSS Active TSS Flanking Bivalent TSS/Enh Weak transcription	n/a	n/a	Overlapped CNVs	n/a
38	rs575058901	chr6:34482845-34482846	Bivalent/Poised TSS Enhancers Bivalent Enhancer Flanking Active TSS Active TSS Flanking Bivalent TSS/Enh Weak transcription	n/a	n/a	Overlapped CNVs	n/a
39	rs536072175	chr6:34482892-34482893	Bivalent/Poised TSS Enhancers Bivalent Enhancer Flanking Active TSS Active TSS Flanking Bivalent TSS/Enh Weak transcription	n/a	n/a	Overlapped CNVs	n/a
40	rs557623879	chr6:34482904-34482905	Bivalent/Poised TSS Enhancers Bivalent Enhancer Flanking Active TSS Active TSS Flanking Bivalent TSS/Enh Weak transcription	n/a	n/a	Overlapped CNVs	n/a
41	rs188683076	chr6:34482916-34482917	Bivalent/Poised TSS Enhancers Bivalent Enhancer Flanking Active TSS Active TSS Flanking Bivalent TSS/Enh Weak transcription	n/a	n/a	Overlapped CNVs	n/a
42	rs545624994	chr6:34482917-34482918	Bivalent/Poised TSS Enhancers Bivalent Enhancer Flanking Active TSS Active TSS Flanking Bivalent TSS/Enh Weak transcription	n/a	n/a	Overlapped CNVs	n/a
43	rs564099292	chr6:34482918-34482919	Bivalent/Poised TSS Enhancers Bivalent Enhancer Flanking Active TSS Active TSS Flanking Bivalent TSS/Enh Weak transcription	n/a	n/a	Overlapped CNVs	n/a
44	rs572759327	chr6:34482945-34482946	Bivalent/Poised TSS Enhancers Bivalent Enhancer Flanking Active TSS Active TSS Flanking Bivalent TSS/Enh Weak transcription	n/a	n/a	Overlapped CNVs	n/a
45	rs540089340	chr6:34482955-34482956	Bivalent/Poised TSS Enhancers Bivalent Enhancer Flanking Active TSS Active TSS Flanking Bivalent TSS/Enh Weak transcription	n/a	n/a	Overlapped CNVs	n/a
46	rs375551621	chr6:34482992-34482993	Bivalent/Poised TSS Enhancers Bivalent Enhancer Flanking Active TSS Active TSS Flanking Bivalent TSS/Enh Weak transcription	n/a	n/a	Overlapped CNVs	n/a
47	rs529017049	chr6:34482995-34482996	Bivalent/Poised TSS Enhancers Bivalent Enhancer Flanking Active TSS Active TSS Flanking Bivalent TSS/Enh Weak transcription	n/a	n/a	Overlapped CNVs	n/a
48	rs4713808	chr6:34483015-34483016	Bivalent/Poised TSS Enhancers Flanking Bivalent TSS/Enh Active TSS Bivalent Enhancer Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
49	rs4713809	chr6:34483053-34483054	Bivalent/Poised TSS Enhancers Flanking Bivalent TSS/Enh Active TSS Bivalent Enhancer Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
50	rs140916092	chr6:34483058-34483059	Bivalent/Poised TSS Enhancers Flanking Bivalent TSS/Enh Active TSS Bivalent Enhancer Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:106)

Disease	PMID	Source
Follicular lymphoma	20505157	CNVD
Glioblastoma multiforme	21080181	CNVD
Ewing''s sarcoma	21437220	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Leukemia	21518781	CNVD
Cancer	21637783	CNVD
Facial dysmorphism	22105932	CNVD
Medulloblastoma	21979893	CNVD
Non-syndromic sensorineural hearing loss	18471307	CNVD
Diffuse large b-cell lymphoma	18287131	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Glioblastoma multiforme	19960244	CNVD
Hepatocellular carcinoma	22174799	CNVD
Endometrial cancer	22040021	CNVD
Acute myeloid leukemia	16864856	CNVD
Breast cancer	21264507	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Cancer	16751803	CNVD
Bladder cancer	19088036	CNVD
Wilms tumour	21544195	CNVD
Uveal melanoma	21693616	CNVD
Biliary cancer	19435499	CNVD
Malaria	21533027	CNVD
Retinoblastoma	19183342	CNVD
Acute myeloid leukemia	20729466	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Prostate cancer	18632612	CNVD
Breast cancer	21858162	CNVD
Ewing''s sarcoma	17952124	CNVD
Autism	21448237	CNVD
Melanoma	18172304	CNVD
Breast cancer	20668451	CNVD
Cancer	20668451	CNVD
Lung cancer	20668451	CNVD
Ovarian cancer	20668451	CNVD
Pancreas cancer	20668451	CNVD
Prostate cancer	20668451	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Hepatocellular carcinoma	16750200	CNVD
Autism	22495311	CNVD
Cancer	16790693	CNVD
Cervical cancer	21062161	CNVD
Esophageal adenocarcinoma	18820669	CNVD
Systemic lupus erythematosus	17503323	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
Urothelial carcinoma	18382360	CNVD
Cancer	21183584	CNVD
Hodgkin''s lymphoma	17606441	CNVD
small cell lung cancer	20016488	CNVD
Oral squamous cell carcinoma	17134496	CNVD
Gastric cancer	17908304	CNVD
Metanephric adenoma	20802469	CNVD
Splenic marginal zone lymphoma	21957467	CNVD
Schizophrenia	19571808	CNVD
Malignant peripheral nerve sheath tumor	18522746	CNVD
Neuroblastoma	16790693	CNVD
T-cell prolymphocytic leukemia	17713554	CNVD
Breast cancer	16397240	CNVD
Retinoblastoma	22278416	CNVD
Non-syndromic sensorineural hearing loss	15273396	CNVD
Systemic lupus erythematosus	20877625	CNVD
Cleidocranial dysplasia	18696259	CNVD
Holoprosencephaly	21359414	CNVD
Liposarcoma	21253554	CNVD
Uveal melanoma	20484589	CNVD
Fibroblasts	20926602	CNVD
Systemic lupus erythematosus	19279649	CNVD
Retinoblastoma	16790693	CNVD
Acute myocardial infarction	18032375	CNVD
Renal cell carcinoma	19150565	CNVD
Systemic lupus erythematosus	19591781	CNVD
Attention deficit hyperactivity disorder	19287146	CNVD
Autism	19287146	CNVD
Erythema nodosum in leprosy	19287146	CNVD
Henoch-schoenlein purpura	19287146	CNVD
Liver cirrhosis	19287146	CNVD
Systemic lupus erythematosus	19287146	CNVD
Autoimmune disease	19135723	CNVD
Congenital adrenal hyperplasia	18478071	CNVD
Systemic lupus erythematosus	19287147	CNVD
Osteosarcoma	16790693	CNVD
Biliary cancer	20360734	CNVD
Breast cancer	20360734	CNVD
Coronary artery disease	20360734	CNVD
Crohn''s disease	20360734	CNVD
Hypertension	20360734	CNVD
Rheumatoid arthritis	20360734	CNVD
Type 1 diabetes	20360734	CNVD
Type 2 diabetes	20360734	CNVD
Cancer	22183965	CNVD
Melanoma	22183965	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Lung cancer	18438408	CNVD
Glioblastoma multiforme	21138945	CNVD
Breast cancer	21364760	CNVD
Basal cell lymphoma	19029149	CNVD
Diffuse large b-cell lymphoma	19029149	CNVD
Myelofibrosis	22110671	CNVD
Liver carcinoma	19366792	CNVD
Chronic lymphocytic leukemia	22228453	CNVD
Non-syndromic sensorineural hearing loss	17122850	CNVD
Amyotrophic lateral sclerosis	20685689	CNVD
Breast cancer	22522925	CNVD
Pancreatic cancer	17952125	CNVD

Chromatin state (count:949 , 50 per page) page: 1 2 3 4 5 6 7 ... 19

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr6:34441400-34494000	Weak transcription	Right Atrium	heart
2	chr6:34479000-34485200	Enhancers	Fetal Brain Male	brain
3	chr6:34479600-34482400	Enhancers	Fetal Adrenal Gland	Adrenal Gland
4	chr6:34480400-34482600	Enhancers	K562	blood
5	chr6:34480800-34482400	Enhancers	Brain Dorsolateral Prefrontal Cortex	brain
6	chr6:34481600-34482400	Enhancers	Cortex derived primary cultured neurospheres	brain
7	chr6:34481600-34482400	Enhancers	Brain Anterior Caudate	brain
8	chr6:34481800-34482400	Weak transcription	H1 BMP4 Derived Mesendoderm Cultured Cells	ES cell derived
9	chr6:34482000-34482400	Enhancers	H1 Derived Neuronal Progenitor Cultured Cells	ES cell derived
10	chr6:34482000-34482400	Active TSS	HUES6 Cell Line	embryonic stem cell
11	chr6:34482000-34482400	Weak transcription	Brain Angular Gyrus	brain
12	chr6:34482000-34482800	Bivalent/Poised TSS	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
13	chr6:34482000-34483000	Bivalent/Poised TSS	iPS-20b Cell Line	embryonic stem cell
14	chr6:34482000-34483000	Active TSS	Brain Inferior Temporal Lobe	brain
15	chr6:34482200-34482400	Flanking Active TSS	iPS-15b Cell Line	embryonic stem cell
16	chr6:34482200-34482400	Active TSS	iPS DF 19.11 Cell Line	embryonic stem cell
17	chr6:34482200-34482400	Enhancers	Ganglion Eminence derived primary cultured neurospheres	brain
18	chr6:34482200-34482400	Bivalent/Poised TSS	Foreskin Fibroblast Primary Cells skin02	Skin
19	chr6:34482200-34482400	Flanking Active TSS	Fetal Brain Female	brain
20	chr6:34482200-34482600	Active TSS	ES-I3 Cell Line	embryonic stem cell
21	chr6:34482200-34482600	Enhancers	Placenta Amnion	Placenta Amnion
22	chr6:34482200-34483000	Bivalent/Poised TSS	H1 Cell Line	embryonic stem cell
23	chr6:34482200-34483000	Bivalent Enhancer	H1 Derived Mesenchymal Stem Cells	ES cell derived
24	chr6:34482200-34483000	Active TSS	HUES48 Cell Line	embryonic stem cell
25	chr6:34482200-34483000	Active TSS	iPS-18 Cell Line	embryonic stem cell
26	chr6:34482200-34483000	Active TSS	iPS DF 6.9 Cell Line	embryonic stem cell
27	chr6:34482200-34483200	Flanking Bivalent TSS/Enh	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived
28	chr6:34482200-34483200	Bivalent/Poised TSS	HUES64 Cell Line	embryonic stem cell
29	chr6:34482200-34483200	Flanking Active TSS	ES-UCSF4 Cell Line	embryonic stem cell
30	chr6:34482200-34483200	Flanking Bivalent TSS/Enh	Foreskin Fibroblast Primary Cells skin01	Skin
31	chr6:34482200-34483400	Active TSS	H9 Cell Line	embryonic stem cell
32	chr6:34482200-34484400	Active TSS	Brain Cingulate Gyrus	brain
33	chr6:34482200-34484400	Flanking Active TSS	Brain Germinal Matrix	brain
34	chr6:34482400-34482600	Enhancers	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
35	chr6:34482400-34482600	Flanking Bivalent TSS/Enh	H9 Derived Neuronal Progenitor Cultured Cells	ES cell derived
36	chr6:34482400-34482600	Bivalent Enhancer	Foreskin Melanocyte Primary Cells skin01	Skin
37	chr6:34482400-34482600	Enhancers	Brain Angular Gyrus	brain
38	chr6:34482400-34482600	Bivalent Enhancer	Fetal Heart	heart
39	chr6:34482400-34482600	Bivalent Enhancer	Fetal Muscle Trunk	muscle
40	chr6:34482400-34482600	Flanking Bivalent TSS/Enh	Fetal Stomach	stomach
41	chr6:34482400-34482600	Bivalent Enhancer	Rectal Mucosa Donor 31	rectum
42	chr6:34482400-34482600	Enhancers	Right Ventricle	heart
43	chr6:34482400-34482600	Bivalent/Poised TSS	Skeletal Muscle Female	skeletal muscle
44	chr6:34482400-34482800	Active TSS	H1 BMP4 Derived Mesendoderm Cultured Cells	ES cell derived
45	chr6:34482400-34482800	Active TSS	H1 Derived Neuronal Progenitor Cultured Cells	ES cell derived
46	chr6:34482400-34482800	Enhancers	Breast Myoepithelial Primary Cells	Breast
47	chr6:34482400-34482800	Active TSS	Brain Dorsolateral Prefrontal Cortex	brain
48	chr6:34482400-34482800	Bivalent Enhancer	Fetal Adrenal Gland	Adrenal Gland
49	chr6:34482400-34482800	Active TSS	Fetal Brain Female	brain
50	chr6:34482400-34483000	Bivalent/Poised TSS	HUES6 Cell Line	embryonic stem cell

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links